+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Rawls-Palmer Progress in Medicine Award

American Society for Clinical Pharmacology and Therapeutics

The Rawls-Palmer Progress in Medicine Award was established in 1978 by Dr. W. B. Rawls to further his commitment to continuing medical education and its impact on patient care. This award was founded through the generosity of the late Dr. and Mrs. W.B. Rawls, and honors the memory of their parents.

The goal of the Rawls-Palmer Progress in Medicine Award is to incorporate the efforts of modern research in patient care and to help bridge the gap between the results of research and its application in patient care. Click here to see the award history and criteria.

Diversity, Equity, and Inclusion
ASCPT is committed to recognizing and promoting excellence in research, collaborations, and efforts that highlight dimensions of diversity. Nominators should address how the candidate has fostered a diverse and inclusive environment.

Prize and Presentation
The Rawls-Palmer Progress in Medicine Award is presented at the ASCPT Annual Meeting. The recipient will present a lecture focusing on recent developments in clinical pharmacology. In addition, the recipient will receive a $1,000 prize and a plaque. Travel expenses, hotel expenses, and meeting registration will be reimbursed by the Society.

AI Based Application Success Predictor

Demonstrated Leadership & Career Impact

Major career awards (e.g., Oscar B. Hunter, Rawls-Palmer) recognize individuals with sustained excellence in drug research, clinical innovation, patient care, and teaching

The Malle Jurima‑Romet Mid‑Career Leadership Award targets those with a clear record of mentorship, team-building, professional growth, service to ASCPT, and initiative ascpt.org.

Scientific & Translational Impact

Awards such as Rawls‑Palmer and Hunter favor translation of research into practice—applicants whose discoveries directly influence therapeutics or clinical care are more competitive careers.

Track Record & Research Productivity

The Darrell Abernethy Early Stage Investigator Award is designed for promising junior faculty with initial publications and evidence of heading independent research

Across all awards, solid publication records and pilot data signal feasibility and investigator caliber.

Protected Time & Institutional Support

Early-stage awards expect applicants to commit ≥60% of their effort toward research

Demonstrated institutional backing—resources, mentorship, nomination letters—is consistently emphasized.

Mentorship & Team Contributions

Eligibility often requires nominations or support from mentors or organizational leaders .

Leadership awards specifically weigh mentoring, team-building, and service to the ASCPT community

Focus on Diversity, Equity & Inclusion (DEI)

ASCPT explicitly seeks nominees who have fostered inclusive environments or made advances benefitting underrepresented communities in research and clinical pharmacology

🔍 Award-specific Predictors

Oscar B. Hunter Career Award:
Recognizes lifelong excellence in research, patient care, and teaching; international recognition is a plus ascpt.org.

Rawls‑Palmer Progress in Medicine:
Prioritizes those whose work has made a transformational impact on clinical pharmacology and its application in patient care

William B. Abrams Geriatric Pharmacology Award:
Focus on investigators contributing to geriatrics pharmacotherapy, particularly in teaching and research, with potential translational benefits .

Malle Jurima‑Romet Mid‑Career Leadership Award:
Requires evidence of sustained leadership, mentorship, professional growth, service, team-building, and initiative .

Darrell Abernethy Early Stage:
Eligibility centers on junior faculty with initial research independence, ≥60% research effort, strong mentorship, initial productivity, and institutional backing .

✅ Summary Table – What Winning Looks Like

✅ Predictor	🧭 Why It Matters
Research productivity	Publications and pilot data demonstrate feasibility and competence
Translational value	Projects must bridge lab research and patient care
Protected research time	Shows institutional commitment to investigator development
Institutional support	Mentor letters, nomination, infrastructure reflect readiness
Mentorship & team skills	Leadership awards require evidence of mentoring, collaboration, and initiative
DEI contributions	Explicit support for inclusion matters in nearly all award categories
International/national reach	Recognition beyond local settings boosts competitiveness

💡 Tips to Strengthen Your Application

Quantify your outputs – include metrics like publications, H-index, grant income.

Emphasize clinical impact – explain how your work has influenced patient care or therapeutic practice.

Document protected effort – outline % time dedicated to research with institutional validation.

Secure strong mentorship – letters from senior mentors, ideally with diverse roles and background.

Highlight mentorship & leadership roles – teaching, team projects, committee work, lab supervision.

Show DEI commitment – mention projects, outreach, or capacity-building in underrepresented settings.

Specialties

Pharmaceuticals

Pharmacology

Eligibility Requirements

A nominee can be an academic, industrial, or regulatory scientist who is widely recognized for their transformational and/or translational discoveries or innovative approaches impacting clinical pharmacology research and clinical practice. A nominee does not need to be an ASCPT member.

Sponsor Details

Sponsor Institute/Organizations: American Society for Clinical Pharmacology and Therapeutics

Sponsor Type: Corporate/Non-Profit

Address: 528 N Washington St, Alexandria, VA 22314 | Ph: 703.836.6981

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity